COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 647: Articles 6461-6470  | Next

SARS-CoV-2 Non-Structural Protein 1(NSP1) Mutation Virulence and Natural Selection: Evolutionary Trends in the Six Continents
Salami Ghaleh, S., Rahimian, K., Mahmanzar, M., Mahdavi, B., Tokhanbigli, S., Mollapour Sisakht, M., Farhadi, A., Mousakhan Bakhtiari, M., Lee Kuehu, D., Deng, Y.
10.1101/2022.07.22.501212 — Posted: 2022-07-26
Visual Transformer and Deep CNN Prediction of High-risk COVID-19 Infected Patients using Fusion of CT Images and Clinical Data
Abbasi, H., Saberi Moghadam Tehrani, S., Zarvani, M., Amiri, P., Azmi, R., Ghods, Z., Nourozi, N., Raoufi, M., Safavi-Naini, S. A. A., Soheili, A., Abolghasemi, S., Gharib, M. J.
10.1101/2022.07.26.22278084 — Posted: 2022-07-26
The highly conserved RNA-binding specificity of nucleocapsid protein facilitates the identification of drugs with broad anti-coronavirus activity
Fan, S., Sun, W., Fan, L., Wu, N., Sun, W., Ma, H., Chen, S., Li, Z., Li, Y., Zhang, J., Yan, J.
10.1101/2022.07.26.501505 — Posted: 2022-07-26
Intranasal delivery of lipid nanoparticle encapsulated SARS-CoV-2 and RSV-targeting siRNAs reduces lung infection
Supramaniam, A., Tayyar, Y., Clarke, D. T., Kelly, G., Morris, K. V., McMillan, N. A., Idris, A.
10.1101/2022.07.25.501479 — Posted: 2022-07-26
Primary Omicron infection elicits weak antibody response but robust cellularimmunity in children
Dowell, A. C., Lancaster, T., Bruton, R., Ireland, G., Bentley, C., Sylla, P., Zuo, J., Scott, S., Jardin, A., Begum, J., Roberts, T., Stephens, C., Amin, U., Ditta, S., Shepherdson, R., Powell, A., Brent, A., Brent, B., Baawuah, F., Okike, I., Beckmann, J., Ahmad, S., Aiano, F., Garstang, J., Ramsay, M., Azad, R., Waiblinger, D., Willet, B., Wright, J., Ladhani, S., Moss, P.
10.1101/2022.07.26.501570 — Posted: 2022-07-26
Effectiveness of the BNT162b2 vaccine against SARS-CoV-2 infection among children and adolescents in Qatar
Chemaitelly, H., AlMukdad, S., Ayoub, H., Altarawneh, H. N., Coyle, P., Tang, P., YASSINE, H. M., Al-Khatib, H. A., Smatti, M. K., Hasan, M. R., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G., Al-Kuwari, M. G., Al-Romaihi, H. E., Butt, A. A., Al-Thani, M. H., Al-Khal, A., Bertollini, R., Abu-Raddad, L. J.
10.1101/2022.07.26.22278045 — Posted: 2022-07-26
Virtual care use among older immigrant adults in Ontario, Canada during the COVID-19 pandemic: a repeated cross-sectional analysis
Brual, J., Chu, C., Fang, J., Fleury, C., Stamenova, V., Bhattacharyya, O., Tadrous, M.
10.1101/2022.07.20.22277848 — Posted: 2022-07-26
#LongCOVID affects children too: A Twitter analysis of healthcare workers sentiment and discourse about Long COVID in children and young people in the UK
Martin, S., Chepo, M., Deom, N., Khalid, A. F., Vindrola-Padros, C.
10.1101/2022.07.20.22277865 — Posted: 2022-07-25
SARS-CoV-2 BA.5 vaccine breakthrough risk and severity compared with BA.2: a case-case and cohort study using Electronic Health Records in Portugal
Kislaya, I., Casaca, P., Borges, V., Sousa, C., Ferreira, B., Fernandes, E., Matias Dias, C., Duarte, S., Almeida, J. P., Coelho, L., Grenho, I., Ferreira, R., Pita Ferreira, P., Isidro, J., Pinto, M., Menezes, L., Sobral, D., Nunes, A., Santos, D., Maia Goncalves, A., Vieira, L., Gomes, J. P., Pinto Leite, P., Nunes, B., Machado, A., Peralta Santos, A.
10.1101/2022.07.25.22277996 — Posted: 2022-07-25
Lowered quality of life in Long COVID is strongly predicted by affective symptoms and chronic fatigue syndrome which are associated with inflammatory processes during the acute infectious phase and consequent neuroimmunotoxic pathways.
Maes, M., Tahseen Al-Rubaye, H., Almulla, A. F., Shihab Al-Hadrawi, D., Stoyanova, K., Kubera, M., Al-Hakeim, H. K.
10.1101/2022.07.25.22277980 — Posted: 2022-07-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).